Results 231 to 240 of about 6,896,550 (362)

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Applying Computational Protein Design to Engineer Affibodies for Affinity-controlled Delivery of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor. [PDF]

Biomacromolecules
Svendsen JE, Ford MR, Asnes CL, Oh SC, Dorogin J, Fear KM, O'Hara-Smith JR, Chisholm LO, Phillips SR, Harms MJ, Hosseinzadeh P, Hettiaratchi MH.   +11 more
europepmc   +1 more source

A Bacterial Growth-Factor Synthesized by a Soil Bacterium [PDF]

, 1952
A. G. Lochhead, Margaret O. Burton, R. H. Thexton   +2 more
openalex   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

From neuromodulation to bone homeostasis: therapeutic targets of nerve growth factor in skeletal diseases. [PDF]

Front Pharmacol
Chen K, Chen L, Ma Y, Chen S, Liu J, Zhou H, Chen Y, Liu G.   +7 more
europepmc   +1 more source

A Study of Some Factors in the Chemical Stimulation of the Growth of Aspergillus niger

, 1919
Robert A. Steinberg
openalex   +2 more sources

The Growth Factor Requirements of Certain Streptococci [PDF]

, 1944
Lemuel D. Wright, Helen R. Skeggs
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Functional expression and secretion of basic fibroblast growth factor in <i>Lactococcus lactis</i>. [PDF]

Front Bioeng Biotechnol
Ho PL, Chua YF, Quek JP, Ng SK, Wong FT, Ow DS.   +5 more
europepmc   +1 more source

Effect of Different Diets and Unidentified Factor Supplements on Reproduction in Chickens and Early Chick Growth

, 1957
Leo S. Jensen, James McGinnis
openalex   +1 more source